Project description
Risk-based strategy for cervical cancer screening
Screening for cervical cancer is a globally recommended public-health policy. To date, limited screening programmes have been implemented, providing suboptimal protection for women at high risk. Development of risk-stratified screening is a priority, as cervical cancer is on the rise in many countries. The EU-funded RISCC project will develop a risk-based screening approach, taking into account history, human papillomavirus (HPV) vaccination status and other relevant risk factors. Risk profiles from screening history will be created using joint data from several large European HPV screening trials. Risk profiles based on vaccination status will be created for cohorts with varying screening and vaccination coverage, using data from community vaccination trials. Finally, RISCC will build open source applications using risk-based screening algorithms to support implementation in real-life programmes.
Fields of science
- medical and health scienceshealth scienceshealth care serviceseHealth
- medical and health scienceshealth sciencespublic health
- medical and health sciencesbasic medicinephysiologycytology
- medical and health sciencesclinical medicineoncologycervical cancer
- medical and health scienceshealth sciencesinfectious diseasesDNA viruses
Programme(s)
Funding Scheme
RIA - Research and Innovation actionCoordinator
1081 HV Amsterdam
Netherlands
See on map
Participants (10)
17177 Stockholm
See on map
69007 Lyon 7eme
See on map
33521 Tampere
See on map
08908 L'hospitalet Del Llobregat
See on map
1050 Elsene
See on map
1000 Ljubljana
See on map
1098 RX Amsterdam
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
1207 Geneva
See on map
10126 Torino
See on map
104 22 Stockholm
See on map